Patents by Inventor Patrice C. Belanger

Patrice C. Belanger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4332807
    Abstract: Novel substituted-benzyl derivatives of 11-endo-amino-5,6,7,8,9,10-hexahydro-2-hydroxy (or methoxy)-6,9-methanobenzocyclooctene (or nonene) of the formula: ##STR1## are centrally-acting analgesics effective in the relief of pain.
    Type: Grant
    Filed: January 26, 1981
    Date of Patent: June 1, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Patrice C. Belanger, Robert N. Young
  • Patent number: 4332810
    Abstract: Novel N-(substituted) derivatives of 2,5-ethano-8-hydroxy (or methoxy)-1,2,3,4,5,6-hexahydro-3 (or 4)-benzazocine of the formula: ##STR1## are centrally acting analgesics effective in the relief of pain.
    Type: Grant
    Filed: January 26, 1981
    Date of Patent: June 1, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Patrice C. Belanger, Robert N. Young
  • Patent number: 4195091
    Abstract: (9-Carboxy-11H-pyrrolo[2,1-b][3]benzazepine-11-ylidene)piperidines useful as appetite stimulants, are prepared by hydrolysis of the corresponding ester or cyano derivatives.
    Type: Grant
    Filed: November 15, 1978
    Date of Patent: March 25, 1980
    Assignee: Merck & Co., Inc.
    Inventors: Joseph G. Atkinson, Patrice C. Belanger, David C. Remy, Clarence S. Rooney
  • Patent number: 4148903
    Abstract: Pyrrolo[2,1-b][3]benzazepines with a piperidinylidene group in the 11-position have utility as antipsychotic agents. They also demonstrate antiserotonin and antihistaminic activity. They are prepared by reaction of a pyrrolo[2,1-b][3]benzazepin-11-one with a piperidinyl magnesium halide followed by dehydration.
    Type: Grant
    Filed: July 28, 1977
    Date of Patent: April 10, 1979
    Assignee: Merck & Co., Inc.
    Inventors: Joseph G. Atkinson, Clarence S. Rooney, Patrice C. Belanger, David C. Remy
  • Patent number: 4145550
    Abstract: Novel 2-(4-substituted-1,2,5-thiadiazol-3-yloxy) acetaldehydes are disclosed. These acetaldehydes are useful as intermediates for preparing certain .beta.-adrenergic blocking agents.
    Type: Grant
    Filed: September 21, 1977
    Date of Patent: March 20, 1979
    Assignee: Merck Sharp & Dohme (I.A.) Corp.
    Inventor: Patrice C. Belanger
  • Patent number: 4076939
    Abstract: Novel 2-(4-substituted-1,2,5-thiadiazol-3-yloxy)acetaldehydes are disclosed. These acetaldehydes are useful as intermediates for preparing certain .beta.-adrenergic blocking agents.
    Type: Grant
    Filed: February 8, 1977
    Date of Patent: February 28, 1978
    Assignee: Merck Sharp & Dohme (I.A.) Corporation
    Inventor: Patrice C. Belanger
  • Patent number: 4056536
    Abstract: 11H-Pyrrolo[2,1-b][3]benzazepin-11-one and derivatives thereof are generally prepared by Friedel-Crafts ring closure of a N-styrylpyrrole-2-carboxylic acid derivative. They are useful intermediates in the synthesis of skeletal muscle relaxants and tranquilizers such as 11-(3-dimethylaminopropylidene)-2-cyano-11H-pyrrolo[2,1-b][3]benzazepine.
    Type: Grant
    Filed: June 29, 1976
    Date of Patent: November 1, 1977
    Assignee: Merck & Co., Inc.
    Inventors: Joseph G. Atkinson, Patrice C. Belanger, Clarence S. Rooney, Susan F. Britcher